Groowe Groowe / Newsroom / NVO
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

NVO News

Novo-Nordisk A/S

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

globenewswire.com
LLY NVO

Best Weight Loss Pills for 2026: FDA Approves First Oral GLP-1 and What It Means for Patients

accessnewswire.com
NVO LLY

Cellarity Provides Strategic Priorities and Outlook for 2026

businesswire.com
NVO

Best Oral Peptides for Weight Loss: Injectable vs Sublingual vs Daily Pill – Direct Meds Consumer Analysis

globenewswire.com
NVO

Pioneering Scientist Behind Revolutionary Weight-Loss Drugs and Leading Mathematician Honored with 2026 King Faisal Prize

globenewswire.com
NVO

Biotechnology Instruments Market Projected to Reach US$ 141.70 Billion by 2035 | Astute Analytica

globenewswire.com
ILMN TMO BRKR LLY ONON PACB RGEN QGEN AMGN BMY GILD NVO ANTX DTIL AGNC DHR

Ozempic From India Now Available at Prices Below U.S. Retail via SaveRxCanada.to International Pharmacy Services

prnewswire.com
NVO

Best Peptides for Weight Loss 2026: Oral Wegovy Launch Expands GLP-1 Format Options as Telehealth Platforms Compare FDA-Approved vs Compounded Semaglutide Access

globenewswire.com
NVO LLY

North Carolina's $10.8 Billion Life Sciences Boom Is Reshaping Research Triangle Industrial Real Estate

globenewswire.com
NVO JNJ

EMED PROVIDES ACCESS TO FDA-APPROVED WEGOVY® PILL THROUGH ITS TRUSTED, CLINICALLY GUIDED MODEL OF CARE

prnewswire.com
NVO